New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer’s disease

BACKGROUND: Amyloid precursor protein (APP), a key molecule in Alzheimer’s disease (AD), is metabolized in two alternative cleavages, generating either the amyloidogenic peptides involved in AD pathology or the soluble form of APP (sAPPα). The level of amyloidogenic peptides in human cerebrospinal f...

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, Christiane, Peoc’h, Katell, Chasseigneaux, Stéphanie, Paquet, Claire, Dumurgier, Julien, Bourasset, Fanchon, Calon, Frédéric, Laplanche, Jean-Louis, Hugon, Jacques, Allinquant, Bernadette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Methodology Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418197/
https://www.ncbi.nlm.nih.gov/pubmed/22824057
http://dx.doi.org/10.1186/1471-2202-13-84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418197/
https://www.ncbi.nlm.nih.gov/pubmed/22824057
http://dx.doi.org/10.1186/1471-2202-13-84

Ejemplares similares